Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Alaunos Therapeutics (TCRT) Times Interest Earned (2021 - 2023)

Alaunos Therapeutics (TCRT) has disclosed Times Interest Earned for 3 consecutive years, with -$7.26 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Times Interest Earned rose 44.99% year-over-year to -$7.26, compared with a TTM value of -$23.94 through Mar 2024, down 129.23%, and an annual FY2023 reading of -$17.84, down 62.6% over the prior year.
  • Times Interest Earned was -$7.26 for Q2 2023 at Alaunos Therapeutics, up from -$10.75 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$7.26 in Q2 2023 and bottomed at -$50.22 in Q3 2021.
  • Average Times Interest Earned over 3 years is -$16.0, with a median of -$11.97 recorded in 2022.
  • The sharpest move saw Times Interest Earned skyrocketed 79.43% in 2022, then increased 19.21% in 2023.
  • Year by year, Times Interest Earned stood at -$14.62 in 2021, then skyrocketed by 42.68% to -$8.38 in 2022, then grew by 13.39% to -$7.26 in 2023.
  • Business Quant data shows Times Interest Earned for TCRT at -$7.26 in Q2 2023, -$10.75 in Q1 2023, and -$8.38 in Q4 2022.